中文|Enterprise Email|OA System|Oracle Clinical
Boji Medical Technology Co., Ltd.
Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Boji Medical Technology Co., Ltd.
Boji Medical Technology Co., Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Boji Medical Technology Co., Ltd.
Boji Medical Technology Co., Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Boji Medical Technology Co., Ltd.
Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Boji Medical Technology Co., Ltd.
Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Boji Medical Technology Co., Ltd.
Boji Medical Technology Co., Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Boji Medical Technology Co., Ltd.
Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
2022 Boji Pharmaceutical Annual Conference was held
The Yangtze River Delta sub-CDE and sub-CMDE was inaugurated!
A talk about “how does Guangzhou create a new height for the bio-medical industry!” "Guangzhou Daily" interviewed Renqiang Ma, Deputy General Manager of Guangzhou Boji Medical biotechnological co.,Ltd.
Boji Medical Technology Co., Ltd.
Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Boji Medical Technology Co., Ltd.
Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Home
About Us
Service Scope
News
Jobs
Contact Us
Investor Relation
Investor Education



"China Securities Regulatory Commission-Investor Risk Tips and Prevention", click to view!

"Shenzhen Stock Exchange-Risk Education for Investor Education" Click to view!

"Guangdong Securities Regulatory Bureau-Investor Protection", click to view!

Typical Case:

1. Cases of "Investor Protection · Rules and Risks"--Beware of the punishment for stock speculation, click to view!

2. Cases of "Investor Protection · Rules and Risks"--There is a way to respect the teacher. Don’t repay the teacher with “insider”, click to view!

3. Cases of "Investor Protection · Rules and Risks"—Leaking news is not a trivial matter, losing money and hurting people, click to view!

4. Cases of "Investor Protection · Rules and Risks"--It is not good to probe the news, stocks still need to go the right way, click to view!

5. Cases of "Investor Protection · Rules and Risks"--Watch out for the traps in the "Daily limit", click to view!

6. Cases of "Investor Protection · Rules and Risks"—There is a mystery in the stock's late rise, do not blindly chase it, click to view!

7. Cases of "Investor Protection · Rules and Risks"-- Pay attention to the change of contract, be more careful when you are close to delivery, click to view!

8. Cases of "Investor Protection · Rules and Risks"—Don't trust "experts" lightly, be careful with recommended stocks, click to view!

9. Cases of "Investor Protection · Rules and Risks"--Be careful about the "flicker" information disclosure of listed companies, click to view!

10. Cases of "Investor Protection · Rules and Risks"—Beware of "high delivery" with impure motivations of listed companies, click to view!

11. Cases of "Investor Protection · Rules and Risks"-- Keep your eyes open and read "Information", click to view!

12. Cases of "Investor Protection · Rules and Risks"-- Changes in equity also require information disclosure. Investors, do you know It? Click to view!

Home/ About Us/ Service Scope/ News/ Jobs/ Contact Us
  • Phone：400-0020-628
  • Address：Clinical Center:7th Floor, Building A, Vanke Cloud Plaza, 1933 Huaguan Road, Tianhe District, Guangzhou / Laboratory Address:No.62,Nanxiang One Road,Huangpu Disrict,Guangzhou
Copyright © Boji Medical Technology Co., Ltd. All Rights Reserved 粤ICP备13039920号 （粤）—非经营性—2020-0084 Powered by vancheer
Copyright © Boji Medical Technology Co., Ltd. All Rights Reserved 粤ICP备13039920号 （粤）—非经营性—2020-0084 Powered by vancheer